MENU
+Compare
ADXN
Stock ticker: NASDAQ
AS OF
Jul 15, 10:45 AM (EDT)
Price
$8.83
Change
-$0.17 (-1.89%)
Capitalization
9.53M

ADXN Addex Therapeutics Ltd Forecast, Technical & Fundamental Analysis

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company... Show more

ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ADXN with price predictions
Jul 14, 2025

ADXN in downward trend: price expected to drop as it breaks its higher Bollinger Band on June 30, 2025

ADXN broke above its upper Bollinger Band on June 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 27 similar instances where the stock broke above the upper band. In of the 27 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for ADXN moved out of overbought territory on June 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 14, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ADXN as a result. In of 131 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ADXN turned negative on July 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADXN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 50-day moving average for ADXN moved above the 200-day moving average on July 03, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADXN advanced for three days, in of 211 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 88 cases where ADXN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.924) is normal, around the industry mean (17.480). P/E Ratio (0.000) is within average values for comparable stocks, (59.327). ADXN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.459). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (58.824) is also within normal values, averaging (273.307).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADXN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADXN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ADXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ADXN is expected to report earnings to fall 22.75% to -3 cents per share on November 13

Addex Therapeutics Ltd ADXN Stock Earnings Reports
Q3'23
Est.
$-0.03
Q2'23
Est.
$-0.04
Q1'23
Missed
by $0.22
Q4'22
Missed
by $1.33
Q3'22
Est.
$-0.09
The last earnings report on August 10 showed earnings per share of -3 cents, meeting the estimate of -3 cents. With 1.20K shares outstanding, the current market capitalization sits at 9.53M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Chemin des Aulx 12
Phone
+41 228841555
Employees
24
Web
https://www.addextherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CATY49.261.16
+2.41%
Cathay General Bancorp
YUMC47.46-0.14
-0.29%
Yum China Holdings
DBI3.11-0.01
-0.32%
Designer Brands
CSPI11.91-0.09
-0.79%
CSP
CPOP0.60-0.09
-13.17%
Pop Culture Group Co Ltd

ADXN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
+0.67%
ANVS - ADXN
43%
Loosely correlated
+5.54%
CVM - ADXN
39%
Loosely correlated
+2.83%
PHAT - ADXN
28%
Poorly correlated
-1.31%
SGMO - ADXN
27%
Poorly correlated
+1.63%
MOLN - ADXN
27%
Poorly correlated
-1.11%
More